Staff Reports
What Do Drug Monopolies Cost Consumers in Developing Countries?
December 2011   Number 530
JEL classification: D4, F13, L1, L65, O34

Author: Rebecca Hellerstein

This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Available only in PDF pdf  11 pages / 141 kb
For a published version of this report, see Rebecca Hellerstein, "What Do Drug Monopolies Cost Consumers in Developing Countries?" Economics Letters 116, no. 1 (July 2012): 108-111.
Tools
E-mail Alerts